We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




POC Fingerprick Test Identifies Both HIV-1/2 and Syphilis Antibodies from One Sample within 60 Seconds

By HospiMedica International staff writers
Posted on 29 Mar 2023
Print article
Image: INSTI Multiplex HIV-1/2 Syphilis Antibody Test provides results for two infections with only one sample (Photo courtesy of bioLytical)
Image: INSTI Multiplex HIV-1/2 Syphilis Antibody Test provides results for two infections with only one sample (Photo courtesy of bioLytical)

HIV and syphilis co-infection is a significant health concern affecting individuals worldwide. Now, a new test is designed to detect antibodies for both HIV-1/2 and syphilis using a single sample obtained through a simple fingerprick method. This test delivers accurate results in under a minute, while being mobile and easy to use. Healthcare professionals can now test individuals in various environments, providing flexible options for those facing barriers to accessing healthcare. The test represents a powerful tool for identifying individuals who require treatment for HIV and/or syphilis, preventing mother-to-child transmission, and reducing the worldwide spread of both infections.

The INSTI Multiplex HIV-1/2 Syphilis Antibody Test from bioLytical Laboratories Inc. (Richmond, BC, Canada) simplifies the testing process by providing results for two infections using just one sample. This innovative approach reduces test anxiety for patients and allows healthcare professionals to test more people in less time. The INSTI Multiplex HIV-1/2 Syphilis Antibody Test has been developed by bioLytical using its proprietary INSTI technology. The portable test is designed for professional use in point-of-care settings but can be performed in a variety of other settings and offers easy-to-understand results.

Clinical studies have shown that the test has a high level of accuracy, with sensitivity and specificity that outperform other tests in the industry. A study the importance of regular and frequent testing to help connect patients to care demonstrated that the real-time results provided by the INSTI platform enabled healthcare professionals to connect patients who tested positive for HIV to care, and the majority of those who tested positive for active syphilis (87.4%) were treated immediately after the point-of-care test results, while the remaining participants were treated within a median of four days.

The INSTI Multiplex HIV-1/2 Syphilis Antibody Test, which has been in use in Europe and Africa since 2016, has now been approved for use in Canada. With syphilis infection rates in Canada reaching unprecedented levels, having increased by 166% nationwide between 2017 and 2021, the approval of this test is a crucial step in addressing this public health issue. Despite decreased access to STBBI services during the pandemic, new infections have continued to increase by 20% between 2020 and 2021 across all demographics. The authorization of the INSTI Multiplex HIV-1/2 Syphilis Antibody Test for professional use in point-of-care settings will provide Canadians with easier access to early testing in various settings, regardless of their demographic.

Related Links:
bioLytical Laboratories 

Gold Member
12-Channel ECG
CM1200B
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Hydrogen Peroxide Sterilizer
HMA-30

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.